SHARON LEELA PATIBANDLA: Open Payments
NPI 1760044796 · CLIFTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,464 in 65 payments from 13 companies in 2025. Trend: 2023 $2,461 · 2024 $2,351 · 2025 $2,464
Food & beverage: $2,464
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $1,050 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $550 |
| Amgen Inc. | 11 | $367 |
| GlaxoSmithKline, LLC. | 9 | $153 |
| ABBVIE INC. | 5 | $88 |
| Dexcom, Inc. | 3 | $71 |
| Lilly USA, LLC | 3 | $49 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Novo Nordisk Inc | 1 | $21 |
Products named: JARDIANCE, FASENRA, BREZTRI, REPATHA, AIRSUPRA, TRELEGY ELLIPTA, OTEZLA, Dexcom G6 Transmitter.
Industry payments across NJ — which companies pay providers there.
